In vivo, in mice hydrodynamically injected with monomeric full length HBV DNA, introduction of TALENs resulted in a
significant reduction of serum HBsAg, HBeAg and liver pregenomic RNA and enhanced the antiviral effects induced by IFN-α when used in combination therapy